Literature DB >> 26923566

Neurotoxicity in Russell's viper (Daboia russelii) envenoming in Sri Lanka: a clinical and neurophysiological study.

Anjana Silva1,2,3, Kalana Maduwage3,4, Michael Sedgwick3, Senaka Pilapitiya2, Prasanna Weerawansa2, Niroshana J Dahanayaka2, Nicholas A Buckley3,5, Sisira Siribaddana2, Geoffrey K Isbister3,4.   

Abstract

CONTEXT: Russell's viper is more medically important than any other Asian snake, due to number of envenoming's and fatalities. Russell's viper populations in South India and Sri Lanka (Daboia russelii) cause unique neuromuscular paralysis not seen in other Russell's vipers.
OBJECTIVE: To investigate the time course and severity of neuromuscular dysfunction in definite Russell's viper bites, including antivenom response.
METHODOLOGY: We prospectively enrolled all patients (>16 years) presenting with Russell's viper bites over 14 months. Cases were confirmed by snake identification and/or enzyme immunoassay. All patients had serial neurological examinations and in some, single fibre electromyography (sfEMG) of the orbicularis oculi was performed.
RESULTS: 245 definite Russell's viper bite patients (median age: 41 years; 171 males) presented a median 2.5 h (interquartile range: 1.75-4.0 h) post-bite. All but one had local envenoming and 199 (78%) had systemic envenoming: coagulopathy in 166 (68%), neurotoxicity in 130 (53%), and oliguria in 19 (8%). Neurotoxicity was characterised by ptosis (100%), blurred vision (93%), and ophthalmoplegia (90%) with weak extraocular movements, strabismus, and diplopia. Neurotoxicity developed within 8 h post-bite in all patients. No bulbar, respiratory or limb muscle weakness occurred. Neurotoxicity was associated with bites by larger snakes (p < 0.0001) and higher peak serum venom concentrations (p = 0.0025). Antivenom immediately decreased unbound venom in blood. Of 52 patients without neurotoxicity when they received antivenom, 31 developed neurotoxicity. sfEMG in 27 patients with neurotoxicity and 23 without had slightly elevated median jitter on day 1 compared to 29 normal subjects but normalised thereafter. Neurological features resolved in 80% of patients by day 3 with ptosis and weak eye movements resolving last. No clinical or neurophysiological abnormality was detected at 6 weeks or 6 months.
CONCLUSION: Sri Lankan Russell's viper envenoming causes mild neuromuscular dysfunction with no long-term effects. Indian polyvalent antivenom effectively binds free venom in blood but does not reverse neurotoxicity.

Entities:  

Keywords:  Antivenom; Daboia russelii; paralysis; single fibre electromyography

Mesh:

Substances:

Year:  2016        PMID: 26923566     DOI: 10.3109/15563650.2016.1143556

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  22 in total

1.  Neurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin.

Authors:  Anjana Silva; Sanjaya Kuruppu; Iekhsan Othman; Robert J A Goode; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Neurotox Res       Date:  2016-07-11       Impact factor: 3.911

Review 2.  Endocrine and Metabolic Manifestations of Snakebite Envenoming.

Authors:  Saptarshi Bhattacharya; Aishwarya Krishnamurthy; Maya Gopalakrishnan; Sanjay Kalra; Viny Kantroo; Sameer Aggarwal; Vineet Surana
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

3.  Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies.

Authors:  Kalana Maduwage; Anjana Silva; Margaret A O'Leary; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

4.  Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming.

Authors:  Anjana Silva; Christopher Johnston; Sanjaya Kuruppu; Daniela Kneisz; Kalana Maduwage; Oded Kleifeld; A Ian Smith; Sisira Siribaddana; Nicholas A Buckley; Wayne C Hodgson; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2016-12-02

Review 5.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

6.  Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2016-10-18       Impact factor: 4.546

7.  Clinical profile of viper envenomations in Kerala, India: some unanswered questions.

Authors:  Maya Gopalakrishnan; Suman Saurabh; Tarun Kumar Dutta
Journal:  Int J Gen Med       Date:  2018-10-03

8.  Detection of Snake Venom in Post-Antivenom Samples by Dissociation Treatment Followed by Enzyme Immunoassay.

Authors:  Kalana P Maduwage; Margaret A O'Leary; Anjana Silva; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2016-04-28       Impact factor: 4.546

9.  Venom proteomics and antivenom neutralization for the Chinese eastern Russell's viper, Daboia siamensis from Guangxi and Taiwan.

Authors:  Kae Yi Tan; Nget Hong Tan; Choo Hock Tan
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

10.  Translational Venomics: Third-Generation Antivenomics of Anti-Siamese Russell's Viper, Daboia siamensis, Antivenom Manufactured in Taiwan CDC's Vaccine Center.

Authors:  Libia Sanz; Sarai Quesada-Bernat; Pei Yu Chen; Cheng Dow Lee; Jen Ron Chiang; Juan J Calvete
Journal:  Trop Med Infect Dis       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.